When used therapeuticallyoften alongside GLP-1 activityGIP can help improve blood sugar regulation, reduce metabolic strain, enhance fat utilization, and support greater body recomposition while preserving lean muscle mass
B12 Deficiency and MTHFR: Individuals with MTHFR mutations may also be more prone to Vitamin B12 deficiencies
A pen with 1 milligram total of semaglutide needs 18 clicks for a 0.25 milligram dose, while a pen containing 0.5 milligrams of semaglutide will require 36 clicks to get that same 0.25 milligram dose
The introduction of incretin based therapies, particularly glucagon like peptide 1 receptor agonists, represented a major advance in the management of metabolic disease
Higher doses or stronger concentrations may increase the chance of side effects
[1] [2] The primary mechanism of action involves: Appetite regulation : Saxenda acts on areas of the brain that control appetite, helping patients feel fuller for longer and reducing hunger between meals [1] [2] Slowing gastric emptying : The medication delays how quickly food leaves the stomach, contributing to prolonged satiety Blood glucose regulation : Although primarily used for weight management, liraglutide also influences insulin secretion and glucagon suppression Saxenda is administered as a once-daily subcutaneous injection, with the dose gradually increased over several weeks to minimise gastrointestinal side effects
